Newsroom
Latest Press Release
Latest News
| January 25, 2012 | | LiveScience: New Vaccine Approach Gives Hope to Those Living with HIV
Most people think of vaccines as a preventative measure, and early efforts to control HIV were focused on that strategy. The problem is that even though some are promising, preventing infection doesn’t do any good for the 34 million people worldwide who are already infected. To stop the spread, the key might be a post-infection vaccine. (to read the full article please click here.)
| | | | November 03, 2011 | | Figyelô: "NANO-SUCCESS" in Hungary
Technology transfer from laboratory to the market. The Hungarian companies proceed on the right way...
Interview with Julianna and Zsolt Lisziewicz.
(Click here to download the PDF version in Hungarian.)
| | | | November 02, 2011 | | Digital Personal Medicine
The CEO of Genetic Immunity, Dr. Julianna Lisziewicz presents the Digital Personalized Medicine approach of DermaVir, the phase II stage therapeutic vaccine against HIV/AIDS at World Vaccine Congress Washington (10 – 13 April 2012, Gaylord National Convention Center, MD, USA.)
Abstract:
Introduction of Digital Personal Medicine (DPM) with DermaVir
- Why do we need to personalize DermaVir and other therapeutic vaccines?
- DermaVir, the first DPM: How does it work?
- Safety and preliminary efficacy of repeated DermaVir immunizations: phase II results from the US and EU
- Challenges and potential solutions in the development of DPM
Facilitating executive level commentary, communication and partnerships between the industry's elite, World Vaccine Congress Washington is where leaders of the World's vaccine community meet to influence and evolve the future of the vaccine industry. Click here for website of World Vaccine Conference.
| | | | See More News... |
| |
|
